IDIBELL on the media
New research will look for risk indicators of harmful internet use among adolescents
Dr. Josep Manuel Menchon, group leader at IDIBELL and head of the Psychiatry Service at Bellvitge University Hospital, participates in a pioneering study led by the University of Hertfordshire to address and reduce the risks of harmful Internet use among adolescents.
Maria Eulàlia Juvé and Jordi Adamuz participate in the publication of a nursing mentoring book
The article by Juvé and Adamuz highlights the importance of knowledge of nursing tools and strategies (ATIC and ARES) to improve patient outcomes and the work environment.
The IDIBELL educational Tandem with the Institut Bellvitge closes the 2022-23 academic year with the launch of new activities
The participation of Institute students in the IDIBELL sLHam for women scientists, the creation of a new Sant Jordi award or the co-creation of content and activities for the new Biomedicine subject have been the main novelties of the course.
A new neuroprotective drug shows good preliminary results for ischemic stroke
According to the results of the APRIL study, in which the Hospital de Bellvitge and IDIBELL have participated, ApTOLL has shown good safety in 151 patients with acute ischemic stroke.
Another year at IDIBELL we maintain our commitment to research, training and innovation to improve people’s health
In 2022, with almost 1,500 published articles, of which almost 600 were led by IDIBELL researchers, our research maintained its high level of quality and excellence, with an average impact factor greater than nine.
A study postulates vaginal self-sample and urine as applicable tools for endometrial cancer diagnosis and prognosis
Two studies led by IDIBELL and the Catalan Institute of Oncology show that DNA sequencing in these samples can detect endometrial cancer, which would avoid much more invasive and painful methods.
IDIBELL and CIBER researchers identify a new genetic disease that affects the development of the nervous system and causes liver failure
RINT1 mutations would be causing a deregulation of fat metabolism and intracellular communication of energy production. This is a significant advance in the understanding of this disease, and opens new perspectives for diagnosis and possible treatment in the future.
New collaboration with Blue Zone Studio to create an OCD monitoring application
The application will monitor in real-time and, combined with neuroimaging studies, will allow the identification of new biomarkers to predict the disease evolution.
Study of brain lesions reveals key connections in epilepsy
A team of researchers including scientists from the Bellvitge Campus, has made a map of lesions of different nature related to epilepsy and discovered that the alteration of a specific neural circuit was common to all the lesions studied.
The natural antioxidant L-Ergothioneine prevents the formation of cystine stones in a murine model of cystinuria
Treatment with L-Ergothioneine manages to increase the solubility of cystine in urine, thus preventing the formation of stones or delaying their appearance. After treatment, an improvement in the oxidative status and mitochondrial function in the kidney is also observed. If these results are validated in future clinical trials, a new preventive treatment for this disease would be available.